Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
06/2008
06/26/2008WO2008074703A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
06/26/2008WO2008074686A1 Substituted 1-(azolin-2-yl)-amino-1,2-heterocyclyl-ethane compounds for combating pests
06/26/2008WO2008047201A3 Solid dispersion comprising a poorly water soluble drug
06/26/2008WO2008038251A3 3-aza-bicyclo[3.1.0]hexane derivatives
06/26/2008WO2008036247A8 Renin inhibitors
06/26/2008WO2006108791A3 Heterocyclylethylheterocyclylcarboxamide derivatives as fungicides
06/26/2008US20080153899 Fatty amine drug conjugates
06/26/2008US20080153873 Dihydrobenzofuranyl derivatives and methods of their use
06/26/2008US20080153872 Bis-(Coumarin) Compounds With Anti-Inflammatory Activity
06/26/2008US20080153857 Specific capsaicin receptor modulators; analgesics; neuropathic pain; obesity; antitussives, hiccups; e.g. (4-Cyclopropyl-phenyl)-[2-methoxymethyl-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl]-amine
06/26/2008US20080153836 1H-Quinazoline-2,4-Diones
06/26/2008US20080153821 Nitrogen-containing 5-membered ring compound
06/26/2008US20080153809 Novel amides useful for treating pain
06/26/2008US20080153799 Novel Quinoline-Carbaxamides as Jak3 Kinase Modulators
06/26/2008CA2695613A1 Sulfonamide derivatives with therapeutic indications
06/26/2008CA2673582A1 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors
06/26/2008CA2673277A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders
06/26/2008CA2672521A1 Pyrazole derivatives as protein kinase inhibitors
06/26/2008CA2672286A1 Organic compounds
06/26/2008CA2672269A1 Organic compounds
06/26/2008CA2671525A1 Indolylmaleimide derivatives
06/26/2008CA2671378A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
06/25/2008EP1935893A1 Total synthesis of pladienolide b and pladienolide d
06/25/2008EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
06/25/2008EP1935882A1 Bicyclic compounds
06/25/2008EP1935879A1 Substituted cycloalkene derivative
06/25/2008EP1934184A1 3 -azabicyclooctane derivatives as muscarinic receptor antagonists
06/25/2008EP1934174A1 Azetidines as mek inhibitors for the treatment of proliferative diseases
06/25/2008EP1730140B1 Opioid receptor antagonists
06/25/2008EP1730119B1 Imidazole compounds for the treatment of neurodegenerative disorders
06/25/2008EP1697350B1 Tricyclic steroid hormone nuclear receptor modulators
06/25/2008EP1606266A4 Chemical compounds
06/25/2008EP1603572A4 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors
06/25/2008EP1556375B1 Flavone derivatives as inhibitors of cyclin-dependent kinases
06/25/2008EP1458393B1 Substituted diketopiperazines as oxytocin antagonists
06/25/2008CN101208329A Pyrimidine derivatives and their use in the treatment of cancer
06/25/2008CN101208302A Novel 4-aminopiperidine derivatives as plasmepsin ii inhibitors
06/25/2008CN101205555A Schistosoma japonicum resistant medicine action target, medicine sifting method and lead compounds
06/25/2008CN100396785C Resoldution method for racemic compound of nucleoside enantiomorph
06/25/2008CN100396682C Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
06/25/2008CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
06/25/2008CN100396678C Synthesis and uses of indole analogs of 1-benzyl-3-(5'-hydroxymethy 1-2' -furyl) indazole
06/25/2008CN100396677C 2-thio-substituted imidazole derivatives and their use in pharmaceutics
06/25/2008CN100396670C N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors, its pharmaceutical composition and use
06/24/2008US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes
06/24/2008US7390907 Vanilloid receptor ligands and their use in treatments
06/24/2008US7390815 Pyrazole compounds useful as protein kinase inhibitors
06/24/2008US7390811 Respiratory syncytial virus replication inhibitors
06/24/2008US7390810 Pyrazole-amine compounds useful as kinase inhibitors
06/24/2008US7390803 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; monocyte chemoattractant protein (MCP) receptor antagonist; antiinflammatory agent; antiallergen; autoimmune diseases; rhinitis, dermatitis, asthma
06/24/2008US7390797 Fused indazole compounds
06/19/2008WO2008073943A1 Dihydrobenzofuranyl derivatives and methods of their use
06/19/2008WO2008073480A1 Compounds and compositions as kinase inhibitors
06/19/2008WO2008073461A2 Ion channel modulators
06/19/2008WO2008073306A1 Organic compounds
06/19/2008WO2008072596A1 Organic electroluminescent device, display and illuminating device
06/19/2008WO2008072190A2 Compositions of azimilide dihydrochloride
06/19/2008WO2008072053A2 Substituted arylpyrazoles
06/19/2008WO2008071951A2 Catalytic process for asymmetric hydrogenation
06/19/2008WO2008071646A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
06/19/2008WO2008071453A1 1,2-diarylacetylene derivatives of acyltryptophanols
06/19/2008WO2008071405A1 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
06/19/2008WO2008043544A8 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators
06/19/2008US20080146818 Dipeptidylpeptidase IV (DPP-IV) inhibitory activity; (2S,4S)-1-[[N-(4-ethoxycarbonylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile)); diabetes
06/19/2008US20080146812 Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
06/19/2008US20080146810 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
06/19/2008US20080146648 Less toxicity; side effects redution; administering substituted p-chlorobenzene and a pyrrolethoxybenzene
06/19/2008US20080146647 Acetylene derivatives having mglur 5 antagonistic activity
06/19/2008US20080146635 Selective to alpha2B and/or alpha2C adrenergic receptors, minimal cardivascular and/or sedatory activity; treating pain, visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion
06/19/2008US20080146627 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain.
06/19/2008US20080146607 heterocyclic ketones such as (3-Benzyl-pyrrolidin-3-yl)-(1H-indol-5-yl)-methanone, used as antidepressants or anxiolytic agents
06/19/2008US20080146589 Chromenone derivatives
06/19/2008US20080146574 Heterocycle Substituted Carboxylic Acids
06/19/2008US20080146545 Macrocyclic compounds useful as inhibitors of kinases and HSP90
06/19/2008CA2672464A1 Dihydrobenzofuranyl derivatives and methods of their use
06/19/2008CA2672233A1 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
06/19/2008CA2672132A1 Compositions of azimilide dihydrochloride
06/19/2008CA2672101A1 Compounds and compositions as kinase inhibitors
06/19/2008CA2671984A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
06/19/2008CA2671970A1 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
06/19/2008CA2671830A1 Catalytic process for asymmetric hydrogenation
06/19/2008CA2670728A1 Pyridine derivatives used as xiap inhibitors
06/18/2008EP1932841A1 Sulfonamide compound
06/18/2008EP1932840A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
06/18/2008EP1932837A1 Bicyclo heterocyclic compound having antifungal action
06/18/2008EP1932833A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
06/18/2008EP1932831A1 1,2-Diarylacetylene Derivatives of Acyltryptophanols
06/18/2008EP1931681A1 Substituted benzofused derivatives and their use as vanilloid receptor ligands
06/18/2008EP1931657A2 Novel high affinity quinoline-based kinase ligands
06/18/2008EP1931656A1 Novel drugs for dementia
06/18/2008EP1931627A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
06/18/2008EP1594861B1 Triazole compounds and the therapeutic use thereof
06/18/2008EP1585521B1 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
06/18/2008EP1443937B1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
06/18/2008CN101203510A Carbon-linked substituted piperidines and derivatives thereof used as histamine H3 antagonists
06/18/2008CN101203509A Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
06/18/2008CN101203495A Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
06/18/2008CN101200465A Decahydronaphthalene compounds and medical uses thereof
06/18/2008CN101200450A 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
06/18/2008CN100395234C Novel CB1 receptour inverse agonists
1 ... 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 ... 694